human | Q5 |
P106 | occupation | researcher | Q1650915 |
Q51641049 | ACE polymorphism and response to electroconvulsive therapy in major depression. |
Q48109119 | BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression |
Q48398086 | Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder |
Q73088634 | Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring |
Q80799539 | Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy |
Q46811961 | Changes in plasma amino acids after electroconvulsive therapy of depressed patients |
Q46311163 | Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy |
Q48243568 | Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein |
Q80222068 | Electroconvulsive therapy in patients with depression and fibromyalgia |
Q80988997 | Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder |
Q48829855 | Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD. |
Q80517681 | One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants |
Q48907841 | P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. |
Q81145441 | RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder |
Q43252463 | TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response |
Q43292426 | TPH2 polymorphisms may modify clinical picture in treatment-resistant depression |
Q81575984 | The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder |
Q43086381 | Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression |
Search more.